Breaks Categories: News

WednesdayJun 05, 2024 3:07 pm

HempNewsBreaks – Alternative Products Expo Returns to Texas for Flagship Global Counterculture Event

Alternative Products Expo (Alt Pro Expo) is preparing to kick off its next in a series of blowout events across North and South America. Presented by ZJ Evets, Alt Pro Expo is slated for June 20–22, 2024, in Houston, Texas. Through the years, Alt Pro Expo has built a reputation for creating a flagship series of events in the global counterculture industry. The agenda for the networking festival includes invaluable education while the exhibit area spotlights an incredible portfolio of innovative products, including vape and hemp products, CBD, disposables, kratom, mushrooms, functional beverages, dietary supplements, nootropics, nicotine replacement, energy enhancers, mood…

Continue Reading

WednesdayJun 05, 2024 2:50 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the second round of dosing for all nine study participants in the second arm of its human pilot study #2 has been completed. The company anticipates completion of the final arm of the study, GLP-1-H24-2, in July. A three-arm, crossover investigation that compares three 7 mg semaglutide dose formulations, the study evaluates three doses: a positive control Rybelsus(R) swallowed tablet; DehydraTECH-semaglutide swallowed capsule; and for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. The study is designed to measure tolerability and side effects as well…

Continue Reading

TuesdayJun 04, 2024 3:12 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Completes Strategic Acquisition

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced the successful completion of its acquisition of Cargo Management Group, a reputable and longstanding shipping, logistics and trucking operation, from TK Zarro, LLC. The acquisition marks a significant milestone in GTV’s expansion efforts, as well as enhancing its operational capabilities within its Lavish Entertainment division and providing a full suite of in-house logistics capabilities for other company operations. Cargo Management Group reported nearly $3 million in revenue for 2023 and brings a robust portfolio of contracts with industry leaders such as JB Hunt, CH Robinson, Coyote Logistics, and Echo Logistics. “The acquisition…

Continue Reading

FridayMay 31, 2024 10:35 am

HempNewsBreaks – CWCBExpo Set to Begin 10th Annual Event, Offer ‘Essential Resources and Information for Success’

Cannabis World Congress & Business Exposition (“CWCBExpo”), the leading East Coast cannabis conference and trade show, is set to begin next week in New York City. The event, which is scheduled for June 5–6, features an immersive exhibition space, leading speakers and presenters, and invaluable business-building opportunities and after parties. This year CWCBExpo partnered with the New York Cannabis Workforce Initiative to showcase workforce development, legal educational programs and colleges that offer cannabis curriculums. In addition, the event agenda provides expanded educational opportunities including two preshow indepth workshops on Dispensary Ownership & Operations Bootcamp and Cultivation: Licensing, Technology & Operation as…

Continue Reading

TuesdayMay 28, 2024 10:23 am

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH), T&K Zarro Ink Agreement to Strengthen Capital Structure, Drive Shareholder Value

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has entered a pivotal agreement with T&K Zarro LLC. Golden Triangle called the agreement a “significant step towards solidifying GTVH's capital structure, expanding its business operations and enhancing shareholder value.” Managed by Tom Zarro, T&K Zarro is the largest note holder in GTVH. The agreement outlines T&K Zarro’s commitment to a “structured and disciplined sale of GTVH stock, limiting sales to no more than 10% of the daily trading volume on any given day.” The agreement also notes a six-month moratorium on all interest accruals within T&K Zarro’s convertible debentures held…

Continue Reading

FridayMay 24, 2024 11:02 am

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Executes LOI to Acquire Cargo Management Group

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, is announcing the execution of a Letter of Intent (“LOI”) with TK Zarro LLC, GTV’s primary note holder, to acquire Cargo Management Group. Golden Triangle Ventures is in the process of finalizing the acquisition. According to the announcement, Cargo Management is a complete shipping, logistics and trucking operation that achieved close to $3 million in top-line revenue in 2023 and presently maintains contracts with prominent corporations including JB Hunt, CH Robinson, Coyote Logistics and Echo Logistics. Cargo Management will support GTV’s Entertainment Division business model, operating under Lavish Entertainment. The announcement…

Continue Reading

ThursdayMay 23, 2024 12:04 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to the announcement, this is the first-ever DehydraTECH(TM)-processed tirzepatide from Zepbound(R) to be tested in a swallowed oral format. The study is designed to evaluate a dual-action GLP-1 (glucagon-like peptide) plus GIP (glucose-dependent insulintropic peptide) in a randomized, crossover investigation that will compare injected Zepbound tirzepatide by Eli Lilly to a compound formulated, DehydraTECH-processed tirzepatide that is derived from Zepbound but in a capsule form. Test articles for the study will be manufactured…

Continue Reading

WednesdayMay 22, 2024 1:18 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Granted Two New US Patents in Hypertension, Epilepsy

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received two new patent awards, bringing the company’s patent portfolio to 43 granted patents worldwide. According to the announcement, the company has been granted a patent in its patent family #21, “Compositions and Methods for Treating Hypertension.” The company noted that this is the third granted U.S. patent in this category and is regarding the company’s DehydraTECH(TM)-processed cannabidiol (“CBD”) and evidence of its ability to lower blood pressure in both acute dosing in hypertension as well as during a five-week study duration. In addition, Lexaria has received a granted patent…

Continue Reading

FridayMay 17, 2024 2:52 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Commencement of Dosing in Comprehensive GLP-1 Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, reported that dosing has begun in its 12-week animal study, WEIGHT-A24-1. The study is designed to model diabetes treatment and weight-loss effects of DehydraTECH(TM)-processed glucagon-like peptide 1 drugs and DehydraTECH-processed cannabidiol (“CBD”), both alone and in combination in diabetic preconditioned rats. According to the announcement, several new areas of investigation are being explored in this study, including evaluating whether DehydraTECH-processed oral GLP-1 drugs are more effective than non-DehydraTECH-processed oral GLP-1 drugs in reaching brain tissue, improving weight loss and improving control of blood sugar. The study will also evaluate…

Continue Reading

TuesdayMay 14, 2024 3:37 pm

HempNewsBreaks – Zoned Properties Inc. (ZDPY) Releases Q1 2024 Financial Results Showing 22% Revenue Growth

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, including legalized cannabis, released its financial results for Q1 2024, the period ended March 31; the company also noted recent business highlights. According to the report, financial highlights include revenues totaling $837,052 for the quarter ended March 31, 2024, compared to $688,024 million revenues for the same quarter 2023, representing an increase of 22%; net income of $96,473, or $0.01 per fully diluted share, as compared to a net loss of $309,648, or ($0.03) per fully diluted share, for the same quarter in 2023, representing…

Continue Reading